Experiments from a murine model of B-ALL treated with anti-CD19 CAR T demonstrated that CAR T cells produced negligible levels of IL-6, but instead bystander proinflammatory monocytes and macrophages were responsible for IL-1 and IL-6 production. Here, CD19 is linked to precursor B-cell acute lymphoblastic leukemia.